WCLC 2025 - Non-Small Cell Lung Cancer

Zongertinib in HER2-Mutant NSCLC With Brain Metastases: Findings From the Beamion LUNG-1 Trial

Zongertinib shows promising efficacy in patients with brain metastases in pretreated HER2-mutant non−small cell lung cancer Read More ›

Videos

Clinical Outcomes in HER2-Mutant NSCLC Treated With Sevabertinib: Insights From the SOHO-01 Phase 1/2 Trial

By Stephanie McDonald, FNP-BC, AOCNP

WCLC 2025 - Non-Small Cell Lung Cancer

Sevabertinib demonstrates promising efficacy and manageable safety in pretreated HER2-mutant non−small cell lung cancer (NSCLC) patients Read More ›

Non-Small Cell Lung Cancer Coverage Brought to You By

WCLC 2025 - Non-Small Cell Lung Cancer